Eric S Orman1, Marwan S Ghabril2, Archita P Desai2, Lauren Nephew2, Kavish R Patidar2, Sujuan Gao3, Chenjia Xu3, Naga Chalasani2. 1. Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana. Electronic address: esorman@iu.edu. 2. Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana. 3. Department of Biostatistics, Indiana University School of Medicine, Indianapolis, Indiana.
Abstract
BACKGROUND & AIMS: Patients with cirrhosis have high rates of hospital readmission, but prediction models are suboptimal and have not included important patient-reported outcome measures (PROMs). In a large prospective cohort, we examined the impact of PROMs on prediction of 30-day readmissions. METHODS: We performed a prospective cohort study of adults with cirrhosis admitted to a tertiary center between June 2014 and March 2020. We collected clinical information, socioeconomic status, and PROMs addressing functional status and quality of life. We used hierarchical competing risk time-to-event analysis to examine the impact of PROMs on readmission prediction. RESULTS: A total of 654 patients were discharged alive, and 247 (38%) were readmitted within 30 days. Readmission was independently associated with cerebrovascular disease, ascites, prior hospital admission, admission via the emergency department, lower albumin, higher Model for End-Stage Liver Disease, discharge with public transportation, and impaired basic activities of daily living and quality-of-life activity domain. Reduced readmission was associated with cancer, admission for infection, children at home, and impaired emotional function. Compared with a model including only clinical variables, addition of functional status and quality-of-life variables improved the area under the receiver-operating characteristic curve from 0.72 to 0.73 and 0.75, with net reclassification indices of 0.22 and 0.18, respectively. Socioeconomic variables did not significantly improve prediction compared with clinical variables alone. Compared with a model using electronically available variables only, no models improved prediction when examined with integrated discrimination improvement. CONCLUSIONS: PROMs may marginally add to the prediction of 30-day readmissions for patients with cirrhosis. Poor social support and disability are associated with readmissions and may be high-yield targets for future interventions.
BACKGROUND & AIMS: Patients with cirrhosis have high rates of hospital readmission, but prediction models are suboptimal and have not included important patient-reported outcome measures (PROMs). In a large prospective cohort, we examined the impact of PROMs on prediction of 30-day readmissions. METHODS: We performed a prospective cohort study of adults with cirrhosis admitted to a tertiary center between June 2014 and March 2020. We collected clinical information, socioeconomic status, and PROMs addressing functional status and quality of life. We used hierarchical competing risk time-to-event analysis to examine the impact of PROMs on readmission prediction. RESULTS: A total of 654 patients were discharged alive, and 247 (38%) were readmitted within 30 days. Readmission was independently associated with cerebrovascular disease, ascites, prior hospital admission, admission via the emergency department, lower albumin, higher Model for End-Stage Liver Disease, discharge with public transportation, and impaired basic activities of daily living and quality-of-life activity domain. Reduced readmission was associated with cancer, admission for infection, children at home, and impaired emotional function. Compared with a model including only clinical variables, addition of functional status and quality-of-life variables improved the area under the receiver-operating characteristic curve from 0.72 to 0.73 and 0.75, with net reclassification indices of 0.22 and 0.18, respectively. Socioeconomic variables did not significantly improve prediction compared with clinical variables alone. Compared with a model using electronically available variables only, no models improved prediction when examined with integrated discrimination improvement. CONCLUSIONS: PROMs may marginally add to the prediction of 30-day readmissions for patients with cirrhosis. Poor social support and disability are associated with readmissions and may be high-yield targets for future interventions.
Authors: Linda Calvillo-King; Danielle Arnold; Kathryn J Eubank; Matthew Lo; Pete Yunyongying; Heather Stieglitz; Ethan A Halm Journal: J Gen Intern Med Date: 2012-10-06 Impact factor: 5.128
Authors: Jessica L Mellinger; Caroline R Richardson; Amit K Mathur; Michael L Volk Journal: Clin Gastroenterol Hepatol Date: 2014-09-28 Impact factor: 11.382
Authors: Jejo D Koola; Sam B Ho; Aize Cao; Guanhua Chen; Amy M Perkins; Sharon E Davis; Michael E Matheny Journal: Dig Dis Sci Date: 2019-09-17 Impact factor: 3.199
Authors: A M Jette; A R Davies; P D Cleary; D R Calkins; L V Rubenstein; A Fink; J Kosecoff; R T Young; R H Brook; T L Delbanco Journal: J Gen Intern Med Date: 1986 May-Jun Impact factor: 5.128
Authors: Betty P Morales; Ramon Planas; Ramon Bartoli; Rosa M Morillas; Margarita Sala; Irma Casas; Carolina Armengol; Helena Masnou Journal: Dig Liver Dis Date: 2017-08-13 Impact factor: 4.088
Authors: Chang Hu; Vikram Anjur; Krishnakant Saboo; K Rajender Reddy; Jacqueline O'Leary; Puneeta Tandon; Florence Wong; Guadalupe Garcia-Tsao; Patrick S Kamath; Jennifer C Lai; Scott W Biggins; Michael B Fallon; Paul Thuluvath; Ram M Subramanian; Benedict Maliakkal; Hugo Vargas; Leroy R Thacker; Ravishankar K Iyer; Jasmohan S Bajaj Journal: Am J Gastroenterol Date: 2021-02-01 Impact factor: 10.864
Authors: P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim Journal: Hepatology Date: 2001-02 Impact factor: 17.425
Authors: Aaron L Leppin; Michael R Gionfriddo; Maya Kessler; Juan Pablo Brito; Frances S Mair; Katie Gallacher; Zhen Wang; Patricia J Erwin; Tanya Sylvester; Kasey Boehmer; Henry H Ting; M Hassan Murad; Nathan D Shippee; Victor M Montori Journal: JAMA Intern Med Date: 2014-07 Impact factor: 21.873